Predictors of surgical outcome and survival among elderly women diagnosed with ovarian and primary peritoneal cancer
- PMID: 16876237
- DOI: 10.1016/j.ygyno.2006.06.019
Predictors of surgical outcome and survival among elderly women diagnosed with ovarian and primary peritoneal cancer
Abstract
Objective: To identify perioperative variables that will predict surgical outcome and survival among elderly women diagnosed with ovarian and primary peritoneal cancer.
Methods: A retrospective review of 78 women>or=75 years treated for ovarian and primary peritoneal cancer from 1/1/90 to 06/30/04 was performed. Patients were categorized in two groups based on optimal versus suboptimal cytoreductive surgery. Perioperative variables were compared across the two groups by univariate and multivariate logistic regression analysis to evaluate the impact on survival.
Results: The median age at the time of diagnosis was 79.3 years. Overall, 50% of the patients underwent optimal cytoreductive surgery. Patients with low perioperative serum albumin levels were associated with a 2.4-fold increased risk of suboptimal cytoreductive surgery (95% CI 1.02-5.88, p=0.04). Median survival of patients that underwent cytoreductive surgery was 19 months. As expected, survival analysis showed that patients with suboptimal cytoreductive surgery had a lower survival (median=17 months) than patients with optimal surgery (median=62 months, p=0.00). Patients>or=80 years were associated with a nearly 2-fold increase in the risk of mortality (95% CI 1.05-3.54, p=0.03), while albumin levels of >or=3.7 g/dl were associated with a 40% reduction in risk of mortality (95% CI 0.41-0.89, p=0.01).
Conclusions: Optimal cytoreductive surgery is feasible in many elderly patients. Women>or=80 years and with poor nutritional status are associated with a poor survival outcome. Perioperative variables such as these can be used to identify the elderly patients that are most likely to be suboptimally cytoreduced and thus have a dismal survival outcome.
Similar articles
-
Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.Gynecol Oncol. 1999 Mar;72(3):278-87. doi: 10.1006/gyno.1998.5145. Gynecol Oncol. 1999. PMID: 10053096
-
Abdominal carcinomatosis in women with a history of breast cancer.Gynecol Oncol. 2005 Oct;99(1):65-70. doi: 10.1016/j.ygyno.2005.05.013. Gynecol Oncol. 2005. PMID: 15979132
-
Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer.Gynecol Oncol. 2007 Oct;107(1):66-70. doi: 10.1016/j.ygyno.2007.05.040. Epub 2007 Jul 5. Gynecol Oncol. 2007. PMID: 17614125
-
Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis.Gynecol Oncol. 2009 Jan;112(1):265-74. doi: 10.1016/j.ygyno.2008.08.033. Epub 2008 Oct 19. Gynecol Oncol. 2009. PMID: 18937969 Review.
-
Splenectomy as part of cytoreductive surgery in ovarian cancer.Gynecol Oncol. 2006 Aug;102(2):369-74. doi: 10.1016/j.ygyno.2006.03.028. Epub 2006 Apr 24. Gynecol Oncol. 2006. PMID: 16631919 Review.
Cited by
-
Prognostic value of preoperative lymphocyte-monocyte ratio in elderly patients with advanced epithelial ovarian cancer.Obstet Gynecol Sci. 2017 Nov;60(6):558-564. doi: 10.5468/ogs.2017.60.6.558. Epub 2017 Oct 31. Obstet Gynecol Sci. 2017. PMID: 29184864 Free PMC article.
-
Validation of a risk-based algorithm to reduce poor operative outcomes after complex surgery for ovarian cancer.Int J Gynecol Cancer. 2023 Jan 3;33(1):83-88. doi: 10.1136/ijgc-2022-003799. Int J Gynecol Cancer. 2023. PMID: 36517075 Free PMC article.
-
The Application and Outcome of Standard of Care Treatment in Elderly Women with Ovarian Cancer: A Literature Review over the Last 10 Years.Front Oncol. 2016 Mar 24;6:63. doi: 10.3389/fonc.2016.00063. eCollection 2016. Front Oncol. 2016. PMID: 27047797 Free PMC article. Review.
-
Serum Albumin Alters [ 18 F]FDG Activity in the Liver and Blood Pool.World J Nucl Med. 2024 Nov 19;24(1):64-70. doi: 10.1055/s-0044-1795100. eCollection 2025 Mar. World J Nucl Med. 2024. PMID: 39959155 Free PMC article.
-
A randomized parallel-group dietary study for stages II-IV ovarian cancer survivors.Gynecol Oncol. 2012 Mar;124(3):410-6. doi: 10.1016/j.ygyno.2011.11.031. Epub 2011 Nov 23. Gynecol Oncol. 2012. PMID: 22119991 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials